Found: 13
Select item for more details and to access through your institution.
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia.
- Published in:
- International Journal of Laboratory Hematology, 2021, v. 43, n. 4, p. 658, doi. 10.1111/ijlh.13580
- By:
- Publication type:
- Article
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2021, v. 14, p. 1303, doi. 10.2147/PGPM.S325813
- By:
- Publication type:
- Article
Management of relapse in acute promyelocytic leukaemia treated with up‐front arsenic trioxide‐based regimens.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. 292, doi. 10.1111/bjh.17221
- By:
- Publication type:
- Article
Resource utilization and cost effectiveness of treating acute promyelocytic leukaemia using generic arsenic trioxide.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 269, doi. 10.1111/bjh.16343
- By:
- Publication type:
- Article
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01357
- By:
- Publication type:
- Article
Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0121912
- By:
- Publication type:
- Article
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience.
- Published in:
- Cytometry. Part B, 2023, v. 104, n. 6, p. 440, doi. 10.1002/cyto.b.22139
- By:
- Publication type:
- Article
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 8, p. 2603, doi. 10.1002/cam4.2883
- By:
- Publication type:
- Article
Degree and Duration of Neutropenia and its Impact on Infections in APL and AML Induction: A Retrospective Case Control Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S236, doi. 10.1016/j.clml.2019.07.125
- By:
- Publication type:
- Article
Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-77140-9
- By:
- Publication type:
- Article
Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 1, p. 1, doi. 10.1002/pbc.29856
- By:
- Publication type:
- Article
Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 523, doi. 10.3390/cells10030523
- By:
- Publication type:
- Article